Brett Wolfson-Stofko1, Alex S Bennett2, Luther Elliott2, Ric Curtis3. 1. National Development & Research Institute, Institute for Special Populations Research, 71 W. 23rd St., 4th Fl., New York, NY 10100, United States of America; Center for Drug Use and HIV/HCV Research, Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10100, United States of America. Electronic address: wolfson-stofko@ndri.org. 2. National Development & Research Institute, Institute for Special Populations Research, 71 W. 23rd St., 4th Fl., New York, NY 10100, United States of America; Center for Drug Use and HIV/HCV Research, Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10100, United States of America. 3. John Jay College of Criminal Justice, City University of New York, Department of Law, Police Science and Criminal Justice Administration, and Department of Anthropology, 524 W. 59th St., New York, NY 10019, United States of America; Center for Drug Use and HIV/HCV Research, Rory Meyers College of Nursing, New York University, 433 First Avenue, New York, NY 10100, United States of America.
Abstract
BACKGROUND: Though public bathroom drug injection has been documented from the perspective of people who inject drugs, no research has explored the experiences of the business managers who oversee their business bathrooms and respond to drug use. These managers, by default, are first-responders in the event of a drug overdose and thus of intrinsic interest during the current epidemic of opioid-related overdoses in the United States. This exploratory study assists in elucidating the experiences that New York City business managers have with people who inject drugs, their paraphernalia, and their overdoses. METHODS: A survey instrument was designed to collect data on manager encounters with drug use occurring in their business bathrooms. Recruitment was guided by convenience and purposive approaches. RESULTS: More than half of managers interviewed (58%, n=50/86) encountered drug use in their business bathrooms, more than a third (34%) of these managers also found syringes, and the vast majority (90%) of managers had received no overdose recognition or naloxone training. Seven managers encountered unresponsive individuals who required emergency assistance. CONCLUSION: The results from this study underscore the need for additional research on the experiences that community stakeholders have with public injection as well as educational outreach efforts among business managers. This research also suggests that there is need for a national dialogue about potential interventions, including expanded overdose recognition and naloxone training and supervised injection facilities (SIF)/drug consumption rooms (DCR), that could reduce public injection and its associated health risks.
BACKGROUND: Though public bathroom drug injection has been documented from the perspective of people who inject drugs, no research has explored the experiences of the business managers who oversee their business bathrooms and respond to drug use. These managers, by default, are first-responders in the event of a drug overdose and thus of intrinsic interest during the current epidemic of opioid-related overdoses in the United States. This exploratory study assists in elucidating the experiences that New York City business managers have with people who inject drugs, their paraphernalia, and their overdoses. METHODS: A survey instrument was designed to collect data on manager encounters with drug use occurring in their business bathrooms. Recruitment was guided by convenience and purposive approaches. RESULTS: More than half of managers interviewed (58%, n=50/86) encountered drug use in their business bathrooms, more than a third (34%) of these managers also found syringes, and the vast majority (90%) of managers had received no overdose recognition or naloxone training. Seven managers encountered unresponsive individuals who required emergency assistance. CONCLUSION: The results from this study underscore the need for additional research on the experiences that community stakeholders have with public injection as well as educational outreach efforts among business managers. This research also suggests that there is need for a national dialogue about potential interventions, including expanded overdose recognition and naloxone training and supervised injection facilities (SIF)/drug consumption rooms (DCR), that could reduce public injection and its associated health risks.
Authors: Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr Journal: N Engl J Med Date: 2006-06-08 Impact factor: 91.245
Authors: Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr Journal: J Public Health (Oxf) Date: 2007-01-17 Impact factor: 2.341
Authors: Tim Rhodes; Jo Kimber; Will Small; John Fitzgerald; Thomas Kerr; Matthew Hickman; Greg Holloway Journal: Addiction Date: 2006-10 Impact factor: 6.526
Authors: Carl Latkin; Aylur K Srikrishnan; Cui Yang; Sethulakshmi Johnson; Sunil S Solomon; Suresh Kumar; David D Celentano; Suniti Solomon Journal: Drug Alcohol Depend Date: 2010-05-13 Impact factor: 4.492
Authors: Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2006-09-07 Impact factor: 4.492
Authors: E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland Journal: N Engl J Med Date: 1989-09-28 Impact factor: 91.245
Authors: Magdalena Cerdá; Yusuf Ransome; Katherine M Keyes; Karestan C Koenen; Kenneth Tardiff; David Vlahov; Sandro Galea Journal: Am J Public Health Date: 2013-10-17 Impact factor: 9.308
Authors: Brett Wolfson-Stofko; Ric Curtis; Faustino Fuentes; Ed Manchess; Alexis Del Rio-Cumba; Alex S Bennett Journal: Dialect Anthropol Date: 2016-11-11
Authors: Rachel Feuerstein-Simon; Margaret Lowenstein; Roxanne Dupuis; Abby Dolan; Xochitl Luna Marti; Alexandra Harvey; Heba Ali; Zachary F Meisel; David T Grande; Noah Lenstra; Carolyn C Cannuscio Journal: J Community Health Date: 2022-01-12